INTS Intensity Therapeutics, Inc. Common stock

USD 2.26 +0.11 ( +5.12%)
Icon

Intensity Therapeutics, Inc. Common stock (INTS) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.26

+0.11 (+5.12%)

USD 0.03B

0.03M

USD 6.75(+198.67%)

N/A

Icon

INTS

Intensity Therapeutics, Inc. Common stock (USD)
COMMON STOCK | NSD
USD 2.26
+0.11 ( +5.12%)

Intensity Therapeutics, Inc. Common stock (INTS) Stock Forecast

Show ratings and price targets of :
USD 6.75
(+198.67%)

Based on the Intensity Therapeutics, Inc. Common stock stock forecast from 2 analysts, the average analyst target price for Intensity Therapeutics, Inc. Common stock is USD 6.75 over the next 12 months. Intensity Therapeutics, Inc. Common stock’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Intensity Therapeutics, Inc. Common stock is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Intensity Therapeutics, Inc. Common stock’s stock price was USD 2.26. Intensity Therapeutics, Inc. Common stock’s stock price has changed by -1.74% over the past week, +21.51% over the past month and -52.32% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...